Tolentino, Loreto E.

HRN: 22-25-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
CEFTRIAXONE 1G (VIAL)
11/25/2022
12/01/2022
IV
2g
OD
Pneumonia
Waiting Final Action 
11/25/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/25/2022
12/01/2022
IV
500mg
Q8
Cholecystitis
Waiting Final Action 
11/28/2022
CEFTAZIDIME 1GM (VIAL)
11/28/2022
12/04/2022
IV
1g
Q8
Sepsis
Waiting Final Action 
12/02/2022
RIFAXIMIN 200MG (TAB)
12/02/2022
12/08/2022
PO
200mg
TID
Sepsis; Gastro Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: